VTVT
vTv Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.35
−0.36%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$1.16
- Revenue estimate
- $333.3K
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$1.05
- EPS estimate
- -$0.97
- Revenue actual
- —
- Revenue estimate
- $333.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +103.1%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $50
- PT range
- $42 – $57
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026